CLINICAL SCIENCES. Irradiation Toxic Effects During Intra-arterial Chemotherapy for Retinoblastoma
|
|
- Jessie Phillips
- 5 years ago
- Views:
Transcription
1 CLINICAL SCIENCES Irradiation Toxic Effects During Intra-arterial Chemotherapy for Retinoblastoma Should We Be Concerned? Rajakrishnan Vijayakrishnan, MD; Carol L. Shields, MD; Aparna Ramasubramanian, MD; Jacqueline Emrich, PhD; Robert Rosenwasser, MD; Jerry A. Shields, MD Objective: To evaluate irradiation toxic effects from fluoroscopy during intra-arterial chemotherapy for retinoblastoma. Design: Prospective trial. Participants: Eight patients treated with intra-arterial chemotherapy. Main Outcome Measures: Irradiation toxic effects in vital organs. Results: The mean patient age was 29 months (range, months) and 63% were male. The mean irradiation dose to the skin of the affected eye was Gy, to the contralateral eye was Gy, to the chest wall was Gy, and to the abdominal wall was Gy. The estimated irradiation dose to the lens in the treatment eye was 0.16 Gy, which, in accumulated doses, could be cataractogenic. The estimated irradiation dose from a single fluoroscopy session to other organs, including the brain ( Gy), thyroid ( Gy), bone marrow ( Gy), and gonads ( Gy), was far lower than the minimal toxic level. Conclusions: Careful use of fluoroscopy during intraarterial chemotherapy with limited irradiation exposure is advised. Accumulated irradiation toxic effects following multiple sessions of intra-arterial chemotherapy could be cataractogenic and possibly carcinogenic, especially in irradiation-sensitive patients with retinoblastoma. Arch Ophthalmol. 2010;128(11): Author Affiliations: Internal Medicine Department, Saint Vincent Hospital, Worcester, Massachusetts (Dr Vijayakrishnan); and Ocular Oncology Service, Wills Eye Institute (Drs C. L. Shields, Ramasubramanian, and J. A. Shields), Department of Radiation Oncology, Hahnemann Hospital (Dr Emrich), and Department of Cerebrovascular Surgery, Thomas Jefferson University (Dr Rosenwasser), Philadelphia, Pennsylvania. INTRA-ARTERIAL CHEMOTHERAPY IS a promising new technique for retinoblastoma management with selective delivery of chemotherapy through the catheterized ophthalmic artery to the eye with minimal systemic chemotherapy adverse effects. Abramson and coworkers 1 evaluated 9 patients with advanced or recurrent retinoblastoma treated with intraarterial chemotherapy and demonstrated remarkable short-term tumor control. Shields and associates 2 confirmed the efficacy of intra-arterial chemotherapy for retinoblastoma in which other treatment methods failed, and they further emphasized the difficulty and necessary precision in catheterization of the obliquely exiting ophthalmic artery from the internal carotid artery in young children. This requires use of cerebral fluoroscopy, which involves short, interrupted exposures to irradiation. As with every new technique, there are concerns for short-term and long-term adverse effects. Local short-term adverse effects of intra-arterial chemotherapy include eyelid edema and ptosis, suprabrow cutaneous erythema and swelling, conjunctival chemosis, temporary restricted ocular motility, retinal detachment, and ophthalmic artery obstruction. Systemic short-term adverse effects of intra-arterial chemotherapy include fever, nausea, and mild transient cytopenia. 1 Long-term adverse effects are yet to be described because this technique has been available in the United States for less than 5 years. Intra-arterial chemotherapy for retinoblastoma is a neuroinvasive procedure and there are serious risks of stroke, cerebral hemorrhage or infection, systemic arterial fibrosis, and other severe neurological problems. Yamane and associates 3 reported extensive experience with 187 children with retinoblastoma who received 563 cannulations (mean, 3 cannulations per patient), with a technical success rate of 98% and no reported cannulation-related complications, such as hemorrhage, stroke, or death. During the procedure of intra-arterial chemotherapy, the catheter is placed transcutaneously into the femoral artery and ad- 1427
2 Table 1. Demographic and Tumor Features of 8 Patients With Retinoblastoma Treated With Intra-arterial Chemotherapy No. (%) Feature (N=8) Age at presentation, mo, mean; median (range) 29; 23 (10-74) Sex M 5 (63) F 3 (37) Race White 7 (88) African American 0 Hispanic 0 Asian 1 (12) Eye affected Right 3 (37) Left 5 (63) Bilateral retinoblastoma 1 (12) Family history of retinoblastoma 0 International Classification of Retinoblastoma Group A 0 Group B 0 Group C 1 (12) Group D 0 Group E 5 (64) Recurrent tumor 2 (24) Tumor features Tumor basal diameter, mm, mean; median 18; 18 (10-22) (range) Tumor thickness, mm, mean; median (range) 8; 8 (3-13) Subretinal seeds No subretinal seeds 3 (37) Focal subretinal seeds 1 (13) Diffuse subretinal seeds 4 (50) Vitreous seeds No subretinal seeds 1 (12) Focal subretinal seeds 1 (12) Diffuse subretinal seeds 6 (76) vanced through the arterial tree into the internal carotid artery and then into the small-caliber ophthalmic artery under fluoroscopic guidance. The cumulative irradiation exposure from fluoroscopy during the procedure has not yet been determined and is important to know, especially for its potential effect on children with germline mutation retinoblastoma. It is well established that exposure to radiotherapy increases the risk for second cancers in germline mutation retinoblastoma. Roarty and coworkers 4 reported that the 30-year cumulative incidence of second cancers in patients with retinoblastoma was 35.1% for patients who received standard external beam radiotherapy compared with an incidence rate of 5.8% for patients who did not receive irradiation. Wong and coworkers 5 determined the dose-response relationship of soft tissue sarcomas and irradiation dose in patients with hereditary retinoblastoma. They reported that the relative risk for soft-tissue sarcoma increased stepwise with dose and that the risk per gray was 19.1% (which is much lower than for other irradiation-induced cancers). They also did not note any sarcomas at an irradiation dose less than 1 Gy. In this publication, we evaluate irradiation exposure from fluoroscopy in children with retinoblastoma treated with intra-arterial chemotherapy at our institution. METHODS Patients with retinoblastoma treated with intra-arterial chemotherapy at Wills Eye Institute in conjunction with the Jefferson Hospital for Neurosurgery at Thomas Jefferson University, Philadelphia, Pennsylvania, between January 2009 and September 2009 were included in the study. Institutional review board approval for intra-arterial chemotherapy was obtained. The clinical data at initial examination included age, race (African American, Hispanic, Asian, white), sex (female, male), affected eye (right, left), family history, laterality, height, and weight. The tumor data included tumor classification (International Classification of Retinoblastoma), tumor basal dimension (in millimeters), tumor thickness (millimeters by ultrasonography), extent of subretinal seeds, and extent of vitreous seeds. During the intra-arterial chemotherapy procedure, microstar radiation dosimeters (Landauer, Glenwood, Illinois) were used to measure the cumulative irradiation exposure at the skin level. For each patient, the dosimeters were placed at the lateral canthus of each eye, thorax (placed on the midsternal line at the level of the nipples), and abdomen (over the umbilicus). The dosimeter values were calculated per each catheterization and the individual organ irradiation exposure was estimated based on previous reports of organ toxic reaction RESULTS There were 8 children with retinoblastoma treated with 11 intra-arterial chemotherapy sessions included in the analysis. The mean age was 29 months (median, 23 months; range, months) and 5 (63%) were male and 3 (37%) were female (Table 1). There were 7 white children (88%) and 1 Asian child (12%). All cases had no family history of retinoblastoma and 7 (88%) had unilateral disease and 1 (12%) had bilateral disease. Genetic analysis was performed on 7 of the 8 patients and was positive in only the child with bilateral retinoblastoma. Only 1 eye was treated in each case (Table 1). The intra-arterial chemotherapy was used as the primary treatment in 6 patients and was used to treat recurrence after previous treatments in 2 patients. The 2 patients in whom intra-arterial chemotherapy was used as a salvage treatment had previously received systemic chemotherapy and local cryotherapy. The clinical features of the tumors are listed in Table 1. The stage of tumor according to International Classification of Retinoblastoma was group A (n=0), group B (n=0), group C (n=1; 12%), group D (n=0), group E (n=5; 64%), and recurrent tumor (n=2; 24%). The mean tumor basal dimension was 18 mm (median, 18 mm; range, mm) and the mean thickness was 8 mm (median, 8 mm; range, 3-13 mm). Subretinal seeds were seen in 5 patients (63%) (focal seeds in 1 [13%] and diffuse seeds in 4 [50%]). Vitreous seeds were seen in 7 patients (88%) (focal seeds in 1 [12%] and diffuse seeds in 6 [76%]). The mean height of the patients was 88 cm (median, 87 cm; range, cm) and the mean weight was 13 kg (median, 12 kg; range, 8-22 kg). The irradiation exposure to each anatomic site is listed in Table 2. The maximum irradiation exposure was to the treatment eye, at a mean of Gy (median, Gy; range, Gy). The irradiation exposure to the contralateral eye was approximately 5 times less compared 1428
3 Table 2. Cutaneous Irradiation Exposure During 11 Sessions of Intra-arterial Chemotherapy Site of Exposure as Measured by microstar Radiation Dosimeters a with the treatment eye, averaging to Gy (median, Gy; range, Gy). This irradiation exposure decreased progressively according to distance from the treatment eye and was approximately 65 times less at the level of the thorax (mean, Gy; median, Gy; range, Gy). The irradiation exposure decreased further at the level of the umbilicus, amounting to approximately 184 times less compared with the treatment eye (mean, Gy; median, Gy; range, Gy). Using previous studies, the correlation between skin entrance dose and organ toxic reaction can be calculated (The percentage of organ irradiation dose to the skin dose was calculated from the reported values in the previous studies.) Though this is only an approximation, it provides a reasonable estimate of irradiation exposure to internal organs. The irradiation dose to the lens was approximately 87% of the ipsilateral lateral canthus skin dose, dose to the brain was 29% of the lateral canthus skin dose, dose to the thyroid gland was 65% of the midsternal chest wall skin dose, dose to the bone marrow was 20%, and dose to the gonads was 14% of the abdominal umbilicus skin irradiation dose Using these organ dose approximations, the internal organ exposure was calculated and is represented in Table 3. The average irradiation dose to the lens in the treatment eye was Gy and to the contralateral eye was Gy. The average dose to the brain was Gy, to the thyroid gland was Gy, to bone marrow was Gy, and to the gonads was Gy. The mean follow-up time after intra-arterial chemotherapy was 4 months (range, 1-6 months). During the follow-up, no lens changes were witnessed in any of the patients. Only 1 patient underwent enucleation during the follow-up period and pathology results did not show any cataractous changes. COMMENT Irradiation Level, Gy (N=11) Treatment eye Mean Median (range) ( ) Contralateral eye Mean Median (range) ( ) Thorax Mean Median (range) ( ) Abdomen Mean Median (range) ( ) a Manufactured by Landauer, Glenwood, Illinois. There are numerous terms to describe irradiation dose to human tissue, including background equivalent radiation time (BERT), critical organ dose (COD), dose area Table 3. Estimated Organ Irradiation Dose During 11 Sessions of Intra-arterial Chemotherapy a Approximate Organ Dose 6-10 Estimated Irradiation Dose, Gy (N=11) Established Irradiation Dose Toxic Level Harmful to the Organ Lens Treatment eye 0.5 Gy 11 Mean Median (range) ( ) Contralateral eye 0.5 Gy 11 Mean Median (range) ( ) Brain Gy 12 Mean Median (range) ( ) Thyroid gland 1.1 Gy 13 Mean Median (range) ( ) Bone marrow 2 Gy 14 Mean Median (range) ( ) Gonads 2 Gy 14 Mean Median (range) ( ) a Superscripts represent the reference number from which the toxic level for the organ was obtained. product (DAP), diagnostic acceptable reference level (DARLing), effective dose (ED), fetal absorbed dose (FAD), total imparted energy (TIE), and surface absorbed dose (SAD). 15 Surface absorbed dose, which is also known as entrance skin dose, is the amount of energy imparted per gram of tissue at the entrance surface. 16 The European Union has identified surface absorbed dose as the diagnostic reference parameter in optimizing irradiation dose 17 and was therefore used as the measurement for irradiation dose in this study. Irradiation imaging of pediatric patients is unique in that the tissues are more radiosensitive in this population and there is a longer lifetime for irradiation-related cancer. 18 Data from atomic bomb survivors have been pivotal in the understanding of irradiation carcinogenesis. Individuals exposed 50 years ago to doses comparable with those associated with helical computed tomography today show a small but statistically significant increased incidence of cancer. Using this information, a child undergoing an abdominal helical computed tomographic scan has a lifetime risk of fatal cancer approximately 1 in Brenner and coworkers 20 reported that the estimated lifetime cancer mortality risks attributable to the irradiation exposure from computed tomography in a 1-year-old are 0.18% (abdominal) and 0.07% (head). Keeping in mind the potential toxic effects of pediatric irradiation exposure, the principle of As Low As Reasonably Achievable (ALARA) should be exercised to minimize irradiation dose. The crystalline lens is one of the most radiosensitive tissues in the body. 21 Recent studies indicate that the threshold for cataract development is less than was previously estimated and is approximately 0.5 Gy. 11 The re- 1429
4 view article by Ainsbury and coworkers 11 summarized the results of recent mechanistic and human studies (including clinical exposure, atomic bomb survivors, Chernobyl, occupational exposure, and space flight exposure). They postulated that previous higher irradiation threshold values were obtained because of shorter follow-up and deficient identification of all cases. In our study, the average irradiation exposure to the lens during a single intra-arterial chemotherapy procedure was 0.16 Gy to the treatment eye and 0.03 Gy to the contralateral eye. The maximum irradiation dose to the lens in our study was 0.4 Gy, which approaches the cataractogenic dose. Also to be considered is the cumulative toxic effects from repeated intra-arterial chemotherapy doses. Most children require 3 to 4 intra-arterial chemotherapy sessions for complete tumor control and this would increase the cumulative dose to the lens, increasing the probability of cataract development in the treatment eye and possibly the contralateral eye. In most instances, irradiation-related cataract develops within 2 to 3 years (range, years), so the exact risk will be evident in the near future. 22 The average brain irradiation dose in our study was 0.05 Gy with a maximum of 0.13 Gy. Studies on stereotactic irradiation have shown that limited brain irradiation at a dose of 50 to 60 Gy is safe with minimal to no discernable effect on memory and cognition. 12 The approximate dose to the brain during intra-arterial chemotherapy is well below the toxic level and therefore likely safe. The thyroid gland in children has one of the highest risk coefficients of any organ and is the only solid organ tissue with convincing evidence for risk at about 1.1 Gy. 13 The thyroid irradiation dose in our study was a mean of Gy with a maximum level of Gy, which is lower than the toxic dose to pediatric thyroid tissue. Ron and coworkers 13 also suggested that spreading the dose over time (from a few days to 1 year) may lower risk, possibly because of the opportunity for cellular repair mechanisms to operate. The average interval between intra-arterial procedures is 4 weeks and this could aid in minimizing organ irradiation toxic effects. The bone marrow and gonads are other structures that have an increased sensitivity to irradiation, particularly in growing children. 18 In our study, the average irradiation dose to bone marrow was Gy (maximum, Gy) and to the gonadal tissue was Gy (maximum, Gy). The irradiation level above which toxic effects appear for bone marrow is 2 Gy and for gonads is 2 Gy. 13,14 The irradiation dose to these organs in this study was far lower than the level of toxic effects. The increased sensitivity of retinoblastoma cells to irradiation has been demonstrated and well documented in cell culture studies. 23,24 Marees and associates 25 reported that the cumulative mortality from any second malignancy 50 years after retinoblastoma diagnosis was 17.3% for patients with hereditary disease. Hence, extra caution needs to be exercised in patients with retinoblastoma with hereditary mutation causing susceptibility to fatal second cancers. Also, the age of the patient prior to considering intra-arterial chemotherapy should be noted because the irradiation susceptibility is higher in patients younger than 1 year. Because intra-arterial chemotherapy is a relatively new technique, the risks and adverse effects are still poorly understood. With better understanding of the irradiation damage during the procedure, the neurovascular interventionalists can modify the fluoroscopy time and dose to minimize toxic effects. In summary, fluoroscopy for catheter guidance is essential for intra-arterial chemotherapy for retinoblastoma. However, concerns exist regarding irradiation toxic effects from fluoroscopy in children. In this analysis, we found that there was a measurable irradiation dose to the lens in the affected eye. The latent period to develop cataract can be very variable, and hence, long-term follow-up is advisable. For patients who have received treatments other than intra-arterial chemotherapy, the lens could be more susceptible to irradiation damage and increase their propensity to develop cataract. The irradiation dose to other organs was lower than the level of toxic effects. Nevertheless, reasonable caution is advised in the use of fluoroscopy during intra-arterial chemotherapy. Children with retinoblastoma are more susceptible to irradiation-related second cancers and could be more prone to malignancy with even low doses of irradiation. Longterm close monitoring of these children is mandatory for both ocular and systemic effects of irradiation and chemotherapy. Submitted for Publication: December 16, 2009; final revision received February 3, 2010; accepted March 10, Correspondence: Carol L. Shields, MD, Ocular Oncology Service, Ste 1440, Wills Eye Institute, 840 Walnut St, Philadelphia, PA (carol.shields@shieldsoncology.com). Author Contributions: Dr Vijayakrishnan has had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Financial Disclosure: None reported. Funding/Support: Support was provided by the Retina Research Foundation of the Retina Society in Cape Town, South Africa (Dr C. L. Shields), the Paul Kayser International Award of Merit in Retina Research, Houston, Texas (Dr J. A. Shields), the LuEsther Mertz Retina Research Foundation, New York, New York (Dr C. L. Shields), and the Eye Tumor Research Foundation, Philadelphia, Pennsylvania (Drs C. L. Shields and J. A. Shields). REFERENCES 1. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8): Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA. Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina. 2009;29(8): Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2): Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988;95(11):
5 5. Wong FL, Boice JD Jr, Abramson DH, et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA. 1997;278(15): Theocharopoulos N, Damilakis J, Perisinakis K, Manios E, Vardas P, Gourtsoyiannis N. Occupational exposure in the electrophysiology laboratory: quantifying and minimizing radiation burden. Br J Radiol. 2006;79(944): Nikolic B, Spies JB, Lundsten MJ, Abbara S. Patient radiation dose associated with uterine artery embolization. Radiology. 2000;214(1): Rybicki F, Nawfel RD, Judy PF, et al. Skin and thyroid dosimetry in cervical spine screening: two methods for evaluation and a comparison between a helical CT and radiographic trauma series. AJR Am J Roentgenol. 2002;179(4): Seidlitz L, Margulis AR. Doses to the vertebral marrow during common x-ray examinations in clinical situations. Invest Radiol. 1974;9(6): Lekovic GP, Kim LJ, Gonzalez LF, Bice A, Albuquerque FC, McDougall CG. Radiation exposure during endovascular procedures. Neurosurgery. 2008;63 (1)(suppl 1):ONS81-ONS Ainsbury EA, Bouffler SD, Dörr W, et al. Radiation cataractogenesis: a review of recent studies. Radiat Res. 2009;172(1): Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol. 2008;3: Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141(3): Halperin EC, Perez CA, Brady LW. Principles and Practice of Radiation Oncology. In: Perez CA, Brady LW, eds. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008: Nickoloff EL, Lu ZF, Dutta AK, So JC. Radiation dose descriptors: BERT, COD, DAP, and other strange creatures. Radiographics. 2008;28(5): Johns HE, Cunningham JR. Conversion from exposure to absorbed dose. In: Johns HE, Cunningham JR, eds. The Physics of Radiology. 4th ed. Springfield, IL: Thomas; 1983: Muhogora WE, Nyanda AM, Kazema RR. Experiences with the European guidelines on quality criteria for radiographic images in Tanzania. J Appl Clin Med Phys. 2001;2(4): Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics. 2003;112(4): Hall EJ. Lessons we have learned from our children: cancer risks from diagnostic radiology. Pediatr Radiol. 2002;32(10): Brenner DJ, Elliston CD, Hall EJ, Berdon WE. Estimated risks of radiationinduced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176(2): Bomford CK, Kunkler IH, Walter J. Walter & Miller s Textbook of Radiotherapy: Radiation Physics, Therapy and Oncology. 6th ed. New York, NY: Churchill Livingstone; 2000: Merriam GR Jr, Worgul BV. Experimental radiation cataract its clinical relevance. Bull N Y Acad Med. 1983;59(4): Weichselbaum RR, Nove J, Little JB. X-ray sensitivity of diploid fibroblasts from patients with hereditary or sporadic retinoblastoma. Proc Natl Acad Sci USA. 1978;75(8): Weichselbaum RR, Nichols WW, Albert DM, Little JB. In vitro radiosensitivity of fibroblasts derived from patients with retinoblastoma and abnormalities of chromosome 13. Retina. 1983;3(2): Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC. Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer. 2009; 45(18): Correction Errors in End Matter. In the Ophthalmic Molecular Genetics article titled Evidence for Keratoconus Susceptibility Locus on Chromosome 14: A Genome-wide Linkage Screen Using Single-Nucleotide Polymorphism Markers by Liskova et al, published in the September issue of the Archives (2010;128[9]: ), 2 sections of end matter were accidently omitted. There should have been an Author Contributions section that read Drs Liskova and Hysi contributed equally to this work. Drs Liskova and Hysi had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. and an Additional Contributions section that read Quincy Prescott, MSc (Institute of Ophthalmology, University College London), provided technical support for the project and Kerra Pearce (UCL Genomics) assisted with sample processing. We thank Alison J. Hardcastle (Institute of Ophthalmology, University College London) for valuable comments on the study design. 1431
CLINICAL SCIENCES. Intra-arterial Chemotherapy for Retinoblastoma. Report No. 1, Control of Retinal Tumors, Subretinal Seeds, and Vitreous Seeds
ONLINE FIRST CLINICAL SCIENCES Intra-arterial Chemotherapy for Retinoblastoma Report No. 1, Control of Retinal Tumors, Subretinal Seeds, and Vitreous Seeds Carol L. Shields, MD; Carlos G. Bianciotto, MD;
More informationDoses from pediatric CT examinations in Norway Are pediatric scan protocols developed and in daily use?
Doses from pediatric CT examinations in Norway Are pediatric scan protocols developed and in daily use? Eva Godske Friberg * Norwegian Radiation Protection Authority, P.O. Box, Østerås, Norway Abstract.
More informationFinancial Disclosures
Retinoblastoma Management: Update Jesse L. Berry, MD Associate Director, Ocular Oncology Service Associate Program Director USC/CHLA, Keck School of Medicine Financial Disclosures Research Support: Bright
More informationManaging the imaging dose during Image-guided Radiotherapy. Martin J Murphy PhD Department of Radiation Oncology Virginia Commonwealth University
Managing the imaging dose during Image-guided Radiotherapy Martin J Murphy PhD Department of Radiation Oncology Virginia Commonwealth University Radiographic image guidance has emerged as the new paradigm
More informationCATARACT IN RETINOBLASTOMA
CATARACT IN RETINOBLASTOMA P R O F. D R A D E L A L E I E L D I N, M D R E S E A E R C H I N S T I T U T E O F O P H T H A L M O L O G Y H E A D O F P E D I A T R I C O P H T H A L M O L O G Y A N D O
More informationArticle Excerpts: Radiation protection concerns among staff performing Fluoroscopic procedures.
Article Excerpts: Radiation protection concerns among staff performing Fluoroscopic procedures. E.P./Cath Lab Pain Management Radiology Contents: Interventional Radiology Carries Occupational Risk for
More informationSITE OF ELECTIVE: OCULAR ONCOLOGY DEPARTMENT, WILLS EYE INSTITUTE, PHILADELPHIA, PENNSYLVANNIA, USA
TEJAL MAGAN FINAL YEAR MEDICAL ELECTIVE REPORT 2015 SITE OF ELECTIVE: OCULAR ONCOLOGY DEPARTMENT, WILLS EYE INSTITUTE, PHILADELPHIA, PENNSYLVANNIA, USA FUNDING: ROYAL COLLEGE OF OPHTHALMOLOGISTS PATRICK
More informationCT Radiation Risks and Dose Reduction
CT Radiation Risks and Dose Reduction Walter L. Robinson, M.S. D.A.B.S.N.M., D.A.B.M.P., D.A.B.R. Consultant Certified Medical Radiation Health & Diagnostic Imaging Physicist Medical Radiation and Children
More informationIndocyanine Green-Enhanced Transpupillary Thermotherapy for Retinoblastoma: Analysis of 42 Tumors
Indocyanine Green-Enhanced Transpupillary Thermotherapy for Retinoblastoma: Analysis of 42 Tumors Murat Hasanreisoglu, MD; Jarin Saktanasate, MD; Rachel Schwendeman, NR-CMA; Jerry A. Shields, MD; Carol
More informationOccupational Cataracts and Lens Opacities in interventional Cardiology: the O CLOC study
Occupational Cataracts and Lens Opacities in interventional Cardiology: the O CLOC study Sophie Jacob, Alexandre Bertrand, Marie-Odile Bernier Institute for Radiological Protection and Nuclear Safety,
More informationIonizing Radiation Exposure from Radiologic Imaging: The Issue and What Can We Do?
Ionizing Radiation Exposure from Radiologic Imaging: The Issue and What Can We Do? Background, The increased use of diagnostic imaging requiring the use of ionizing radiation, the rapidly expanding use
More informationSelective Intra-Ophthalmic Artery Chemotherapy for Advanced Intraocular Retinoblastoma: CCHMC Early Experience. A thesis submitted to the
Selective Intra-Ophthalmic Artery Chemotherapy for Advanced Intraocular Retinoblastoma: CCHMC Early Experience A thesis submitted to the Graduate School of the University of Cincinnati in partial fulfillment
More informationEstimates of Risks LONG-TERM LOW DOSE EFFECTS OF IONIZING RADIATION
Estimates of Risks LONG-TERM LOW DOSE EFFECTS OF IONIZING RADIATION Low Level Radiation Exposure Single exposure of 10 rad or less Larger exposures delivered over periods of days or longer (low dose
More informationCLINICAL SCIENCES. with thermotherapy or cryotherapy is an important
CLINICAL SCIENCES Macular Retinoblastoma Managed With Chemoreduction Analysis of Tumor Control With or Without Adjuvant Thermotherapy in 68 Tumors Carol L. Shields, MD; Arman Mashayekhi, MD; Jacqueline
More informationThe Egyptian Journal of Hospital Medicine (October 2018) Vol. 73 (9), Page
The Egyptian Journal of Hospital Medicine (October 2018) Vol. 73 (9), Page 7412-7417 Mohammad Ahmad Wahdan 1, Abd Allah El Hussainy Shaleel 1, Hossam El Dein Ahmed El Zomor 2, Hossam El Din Hassan El Sayed
More informationTiffany L. Kruger, D.O. Children s Hospital of Michigan Wayne State University/Kresge Eye Institute
Pediatric Cases Nt Not To Be Missed Tiffany L. Kruger, D.O. Pediatric Ophthalmology Fellow Children s Hospital of Michigan Wayne State University/Kresge Eye Institute Case Presentation CC: Left eye turns
More informationPEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING
PEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING ANATOMY ANATOMY CONT ANATOMY CONT. ANATOMY CONT. EYE OF A CHILD Normal tissue tolerance doses (in conventional #) TD 5/5 TD 50/5 Endpoint Gy Gy Optic nerve
More informationDebra Pennington, MD Director of Imaging Dell Children s Medical Center
Debra Pennington, MD Director of Imaging Dell Children s Medical Center 1 Gray (Gy) is 1 J of radiation energy/ 1 kg matter (physical quantity absorbed dose) Diagnostic imaging doses in mgy (.001 Gy)
More informationRadiation Dose in Pediatric Imaging
Radiation Dose in Pediatric Imaging A Brief History of Radiology Dose: Why Does It Matter? Measuring Exposure and Dose Deterministic Effects Stochastic Effects Common Exams: What is the Risk? Reducing
More informationUtilize radiation safety principles to reduce the amount of radiation used to achieve desired clinical result.
Minimizing Dose Understand the importance and methods of pre-procedure patient assessment including a review of previous radiologic exams, disease processes and anatomical considerations that may increase
More informationIonizing Radiation Exposure from Radiologic Imaging
Ionizing Radiation Exposure from Radiologic Imaging Background The increased use of diagnostic imaging requiring the use of ionizing radiation, the rapidly expanding use of computed tomography in the emergency
More informationDose-equivalent equivalent = absorbed
UCSF General Surgery 2010 Radiation Risks of Diagnostic Radiology in Trauma Robert A. Izenberg, M.D., FACS University of California, San Francisco San Francisco General Hospital Context Increasingly liberal
More informationCLINICAL SCIENCES. Intra-arterial Chemotherapy for Retinoblastoma
ONLINE FIRST CLINICAL SCIENCES Intra-arterial Chemotherapy for Retinoblastoma Report No. 2, Treatment Complications Carol L. Shields, MD; Carlos G. ianciotto, MD; Pascal Jabbour, MD; Gregory C. Griffin,
More informationBiological Effects of Ionizing Radiation Module 8 - AAPM/RSNA Curriculum. Basic Radiation Biology
Biological Effects of Ionizing Radiation Module 8 - AAPM/RSNA Curriculum Basic Radiation Biology Kalpana M. Kanal, PhD, DABR Associate Professor, Radiology Director, Resident Physics Education a copy of
More informationSTUDIES OF LOW-DOSE RADIATION AND CANCER. E. Lubin
STUDIES OF LOW-DOSE RADIATION AND CANCER E. Lubin 1 RELEVANT DATA BEIR VII 2006 UNSCEAR 2000 ICRP PIERCE D. PRESTON DL Japanese survivors. CARDIS E. IARC occupational exposure. BRENNER D. CT exposure and
More informationEpidemiologic Studies of Radiation Cataract Risk
Epidemiologic Studies of Radiation Cataract Risk Roy Shore hrshore@gmail.com New York University School of Medicine and Radiation Effects Research Foundation (retired) Overview of Presentation Selected
More informationBackground Radiation in U.S. ~ msv/yr msv/yr ~0.02 ~0.02 msv msv/day /day (~2 m rem/day) mrem/day) NCRP 4
Patient Safety Concerns in Diagnostic Radiology? Lawrence T. Dauer, PhD, CHP Assistant Attending Health Physicist Department of Medical Physics RAMPS/GNYCHPS Spring Symposium April 30, 2010 Benefits?
More informationEarly detection of Retinoblastoma in children. Max Mantik
Early detection of Retinoblastoma in children Max Mantik Introduction The most common primary intraocular malignancy of childhood 10 to 15 % of cancers that occur within the first year of life Typical
More informationRetinoblastoma. all information provided by:
basic information & treatment plans of Retinoblastoma all information provided by: Ocular Oncology Service Wills Eye Hospital Philadelphia, PA 840 WALNUT STREET SUITE 1440, PHILADELPHIA, PA 19107 WWW.FIGHTEYECANCER.COM
More informationRADIATION SAFETY. Junior Radiology Course
RADIATION SAFETY Junior Radiology Course Expectations for the Junior Radiology Course Medical School wants students to learn basic principles, factual knowledge, safety info, etc. Medical Students want
More informationRadiation Safety in the Catheterization Lab
SCAI FALL FELLOWS COURSE - 2015 Radiation Safety in the Catheterization Lab V. Vivian Dimas, MD, FSCAI Associate Professor Pediatrics, Cardiology UT Southwestern Medical Center Dallas TX None Disclosures
More informationExtracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 2, SPRING 2006 Extracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas Thomas Samuel Ram, a Paul B. Ravindran,
More informationBilateral Retinoblastoma Joseph Junewick, MD FACR
Bilateral Retinoblastoma Joseph Junewick, MD FACR 06/11/2010 History 17 month old adopted female with proptosis. Diagnosis Bilateral Retinoblastoma Discussion Retinoblastoma is the most common pediatric
More informationRadiation Safety for New Medical Physics Graduate Students
Radiation Safety for New Medical Physics Graduate Students John Vetter, PhD Medical Physics Department UW School of Medicine & Public Health Background and Purpose of This Training This is intended as
More informationCHEMOREDUCTION FOR RETINOBLASTOMA: ANALYSIS OF TUMOR CONTROL AND RISKS FOR RECURRENCE IN 457 TUMORS
CHEMOREDUCTION FOR RETINOBLASTOMA: ANALYSIS OF TUMOR CONTROL AND RISKS FOR RECURRENCE IN 457 TUMORS BY Carol L. Shields MD,* Arman Mashayekhi MD, Jacqueline Cater PhD, Abdallah Shelil MD, Anna T. Meadows
More information2016 myresearch Science Internship Program: Radiology. Civic Education Office of Government and Community Relations
2016 myresearch Science Internship Program: Radiology Civic Education Office of Government and Community Relations Kayla Siladi Science Internship Program: Radiology Pediatric Computed Tomography Scans
More informationSuccessful Treatment of Macular Retinoblastoma With Superselective Ophthalmic Artery Infusion of Melphalan
Successful Treatment of Macular Retinoblastoma With Superselective Ophthalmic Artery Infusion of Melphalan Theodora Hadjistilianou, MD; Gianni Coriolani, MD; Sandra racco, MD; Paola Gennari, MD; Mauro
More informationUpdate on Intraocular Oncology
Update on Intraocular Oncology Suganeswari Ganesan Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya Correspondence to: Suganeswari Ganesan, Consultant, Vitreoretinal and Oncology services,
More informationEffects of Long-Term Exposure to Radiation. Tim Marshel R.T. (R)(N)(CT)(MR)(NCT)(PET)(CNMT)
Effects of Long-Term Exposure to Radiation Tim Marshel R.T. (R)(N)(CT)(MR)(NCT)(PET)(CNMT) SNMTS Approved MIIWIIQI: Effects of Long Term Exposure to Radiation 45 Hr PET Registry Review Course Reference
More information2013 Coding Changes. Diagnostic Radiology. Nuclear Medicine
2013 Coding Changes The principal coding changes affecting Radiologists in 2013 occur in the Interventional Radiology Section of the AMA/CPT Manual. As in the past, we continue to see the Relative Update
More informationSpinal Cord Doses in Palliative Lung Radiotherapy Schedules
Journal of the Egyptian Nat. Cancer Inst., Vol. 8, No., June: -, 00 Spinal Cord Doses in Palliative Lung Radiotherapy Schedules HODA AL-BOOZ, FRCR FFRRCSI M.D.* and CAROL PARTON, Ph.D.** The Departments
More informationDosimetric Consideration in Diagnostic Radiology
Dosimetric Consideration in Diagnostic Radiology Prof. Ng Kwan-Hoong Department of Biomedical Imaging University of Malaya ngkh@um.edu.my Radiation Dosimetry Workshop, 28-29 March 2014 2 Why do we measure
More informationWhy radiation protection matters?
Why radiation protection matters? Elias Brountzos Professor of Radiology 2 nd Department of Radiology Medical School, University of Athens Athens, Greece A definition for radiation protection Radiation
More informationRetina Center of Oklahoma Sam S. Dahr, M.D. Adult Intraocular Tumors
Adult Intraocular Tumors Sam S. Dahr, M.D. Retina Center of Oklahoma www.retinacenteroklahoma.com www.rcoklahoma.com Table of Contents Posterior uveal malignant melanoma Uveal metastasis Uveal melanoma
More informationManaging Patient Dose in Computed Tomography (CT)
Managing Patient Dose in Computed Tomography (CT) International Commission on Radiological Protection Information abstracted from ICRP Publication 87 Available at www.icrp.org Task Group: M.M. Rehani,
More informationRadiation Exposure 1980 to 2006
Radiation Exposure 1980 to 2006 Background 3-6 msv/yr Natural (85% 45%) Radon Cosmic Rays Air travel Living at Altitude Man-made (15% 55%) Medical Imaging** mgy Radiation Therapy cgy Radiation Whole Body
More informationCurrent status of diagnostic imaging in dental university hospitals in Japan
Oral Radiol (2004) 20:15 21 Japanese Society for Oral and Maxillofacial Radiology and Springer-Verlag Tokyo 2004 DOI 10.1007/s11282-004-0010-3 ORIGINAL ARTICLE Takehito Sasaki Minoru Fujita Tsuguhisa Katoh
More informationIntra-arterial chemotherapy for retinoblastoma: a practical review
326 Balderrama et al Intra-arterial chemotherapy for retinoblastoma Intra-arterial chemotherapy for retinoblastoma: a practical review Jorge Balderrama 1, Carlos A. Leal-Leal 2, Hernando Alvis-Miranda
More informationMedical students awareness of radiation exposure related to radiological imaging procedures
ORIGINAL PAPER Medical students awareness of radiation exposure related to radiological imaging procedures Katarzyna Jończyk-Potoczna 1, Lidia Strzelczuk-Judka 1, Ewa Szłyk 1, 2, Łucja Stefaniak 1, 2 1
More informationManaging Patient Dose in Computed Tomography (CT) INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION
Managing Patient Dose in Computed Tomography (CT) International Commission on Radiological Protection Information abstracted from ICRP Publication 87 Available at www.icrp.org Task Group: M.M. Rehani,
More informationRadiation Safety For Anesthesiologists. R2 Pinyada Pisutchareonpong R2 Nawaporn Sateantantikul Supervised by Aj Chaowanan Khamtuicrua
Radiation Safety For Anesthesiologists R2 Pinyada Pisutchareonpong R2 Nawaporn Sateantantikul Supervised by Aj Chaowanan Khamtuicrua Modern World Non Ionizing VS Ionizing Non Ionizing Harmless Ex. visible
More informationCancer Risks from CT Scans: Now We Have Data What Next?
Cancer Risks from CT Scans: Now We Have Data What Next? David J. Brenner, PhD, DSc Center for Radiological Research Columbia University Medical Center djb3@columbia.edu There is no question that CT has
More informationSteven Aaron Ross, M.D. Pediatric Radiologist El Paso Imaging Consultants El Paso Children s Hospital
Steven Aaron Ross, M.D. Pediatric Radiologist El Paso Imaging Consultants El Paso Children s Hospital I will prescribe regimens for the good of my patients according to my ability and my judgment and never
More informationDisclosure. Paul Medin teaches radiosurgery courses sponsored by BrainLAB Many animals (and humans) were harmed to make this presentation possible!
Disclosure The tolerance of the nervous system to SBRT: dogma, data and recommendations Paul Medin, PhD Paul Medin teaches radiosurgery courses sponsored by BrainLAB Many animals (and humans) were harmed
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationSkyscan 1076 in vivo scanning: X-ray dosimetry
Skyscan 1076 in vivo scanning: X-ray dosimetry DOSIMETRY OF HIGH RESOLUTION IN VIVO RODENT MICRO-CT IMAGING WITH THE SKYSCAN 1076 An important distinction is drawn between local tissue absorbed dose in
More informationAssessing the standard dose to standard patients for x-ray investigations
Assessing the standard dose to standard patients for x-ray investigations A. Almén and W. Leitz Swedish Radiation Protection Authority, SE-171 16 Stockholm, Sweden E-mail: anja.almen@ssi.se Abstract. The
More informationJ of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 55/ July 09, 2015 Page 9665
RARE PRESENTATION OF BILATERAL CHOROIDAL METASTASIS FROM PRIMARY MUCO-EPIDERMOID CARCINOMA OF THE PAROTID GLAND: A G. Premalatha 1, Ramya Seetamraju 2 HOW TO CITE THIS ARTICLE: G. Premalatha, Ramya Seetamraju.
More informationRadiation exposure of the Yazd population from medical conventional X-ray examinations
Iran. J. Radiat. Res., 2007; 4 (4): 195-200 Radiation exposure of the Yazd population from medical conventional X-ray examinations F. Bouzarjomehri 1*, M.H. Dashti 2, M.H. Zare 1 1 Department of Medical
More informationA RESOURCE MANUAL MANAGEMENT RETINOBLASTOMA LOW & MIDDLE RESOURCE SETTINGS
A RESOURCE MANUAL FOR THE MANAGEMENT OF RETINOBLASTOMA IN LOW & MIDDLE RESOURCE SETTINGS UPDATED SEPTEMBER 2017 1 CONTENTS PAGE INTRODUCTION 3 SERVICE LEVEL for Rb MANAGEMENT 4 SCREENING 5 EARLY DIAGNOSIS
More informationNon-target dose from radiotherapy: Magnitude, Evaluation, and Impact. Stephen F. Kry, Ph.D., D.ABR.
Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact Stephen F. Kry, Ph.D., D.ABR. Goals Compare out-of-field doses from various techniques Methods to reduce out-of-field doses Impact of
More informationRadiation Related Second Cancers. Stephen F. Kry, Ph.D., D.ABR.
Radiation Related Second Cancers Stephen F. Kry, Ph.D., D.ABR. Objectives Radiation is a well known carcinogen Atomic bomb survivors Accidental exposure Occupational exposure Medically exposed Radiotherapy
More informationThe Risk of Cataract Associated With Repeated Head and Neck CT Studies: A Nationwide Population-Based Study
Neuroradiology/Head and Neck Imaging Original Research Yuan et al. CT-Associated Risk of Developing Cataract Neuroradiology/Head and Neck Imaging Original Research Mei-Kang Yuan 1,2 Der-Chong Tsai 3 Shih-Chieh
More informationSecond Neoplasms Working Group. CCSS Investigators Meeting June 2017
Second Neoplasms Working Group CCSS Investigators Meeting June 2017 Second Neoplasms Working Group Overview Ongoing review, adjudication and entry of reported neoplasms into data set Initial review of
More informationPulmonary changes induced by radiotherapy. HRCT findings
Pulmonary changes induced by radiotherapy. HRCT findings Poster No.: C-2299 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, M. Albert Antequera, K. Müller Campos, D. 1 2 4 3 1
More information3/5/2015. Don t Electrocute Me!: Common Misconceptions in Imaging and Radiation Safety (and What to Do About Them)
Don t Electrocute Me!: Common Misconceptions in Imaging and Radiation Safety (and What to Do About Them) Rebecca Milman Marsh, Ph.D. University of Colorado Department of Radiology Who in the Facility Works
More informationThe Increasing Use of CT and Its Risks
STUDENT SCOPE The Increasing Use of CT and Its Risks Matthew Voress is a radiography student at Owens Community College in Toledo, Ohio. This article was awarded first prize in the Ohio Society of Radiologic
More informationLaboratory Safety 197/405. Types of Radiation 198/405
Laboratory Safety 197/405 Types of Radiation 198/405 Particle Radiation Alpha He nucleus (heavy particle) +2 charge Internal hazard only Beta Electron -1 charge Internal and external hazard Neutron 199/405
More informationSecondary Tumors After Hereditary Retinoblastoma: A Case of Orbital Leiomyosarcoma 50 Years After Initial Enucleation and Radiation Therapy
Secondary Tumors After Hereditary Retinoblastoma: A Case of Orbital Leiomyosarcoma 50 Years After Initial Enucleation and Radiation Therapy John J Chen, MD, PhD and Richard C Allen, MD, PhD November 28,
More informationPaediatric Dose Reduction and Image Quality
Paediatric Dose Reduction and Image Quality Alan Whiteside The majority of this work was undertaken as part of MSc Thesis of Helen Dixon. Introduction Paediatric CT protocols result in a higher effective
More informationPatient Radiation Doses from Adult and Pediatric CT
Radiation Doses from CT CT Imaging Original Research Walter Huda 1 Awais Vance 1,2 Huda W, Vance A Keywords: MDCT, pediatric CT, physics of radiology, radiation dose DOI:.2214/AJR.06.01 Received January
More informationOut-of-field organ doses from therapeutic irradiation during childhood: is there an excess risk for second cancer induction?
Out-of-field organ doses from therapeutic irradiation during childhood: is there an excess risk for second cancer induction? Poster No.: C-0096 Congress: ECR 2012 Type: Scientific Paper Authors: M. Mazonakis,
More informationEstimating Risks from CT Scans - in the Context of CT Scan Benefits
Estimating Risks from CT Scans - in the Context of CT Scan Benefits David J. Brenner Center for Radiological Research Columbia University Medical Center djb3@cumc.columbia.edu There is no question that
More informationErnest Rutherford:
November 1895: Roentgen discovers x rays February 1896: Becquerel discovers radioactivity Ernest Rutherford 1898-99 Ernest Rutherford: 1898-99 The Electromagnetic Spectrum Interaction of Charged Particles
More informationEstimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review
Pediatr Radiol (1) :681 686 DOI 1.17/s247-9-1434-z ORIGINAL ARTICLE Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review Soni C. Chawla & Noah Federman
More informationLeukemia: Lessons from the Japanese Experience
Leukemia: Lessons from the Japanese Experience STUART C. FINCH Cooper Hospital, Camden, New Jersey, USA Key Words. Leukemia. Japan Life Span Study Atomic bomb. Radiation ABSTRACT Probably more has been
More informationRADIUM TREATMENT FOR HEMANGIOMA IN EARLY CHILDHOOD
Acia Oncologica 29 (1990) Fax. 5 FROM THE DEPARTMENT OF HOSPITAL PHYSICS, AND THE DEPARTMENTS OF GENERAL ONCOLOGY AND CANCER PREVENTION, RADIUMHEMMET, KAROLINSKA HOSPITAL, STOCKHOLM, SWEDEN. RADIUM TREATMENT
More informationPseudohypopyon in Retinoblastoma. Choroidal Nevus. Masquerade Syndromes. Vision pathways. Flat with uniform color
Primary Intraocular Tumors Thomas F. Freddo, O.D., Ph.D., F.A.A.O. Professor and Former Director School of Optometry University of Waterloo Masquerade Syndromes
More informationTransvitreal Fine Needle Aspiration Biopsy of Choroidal Melanoma via Pars Plana Vitrectomy
Surgical Technique Is pars plana vitrectomy a safe method for performing fine needle aspiration biopsy of choroidal melanoma? What are the rates of complications? Clinical Characteristics Do tumor thickness
More information20. Background. Oligometastases. Oligometastases: bone (including spine) and lymph nodes
125 20. Oligometastases Background The oligometastatic state can be defined as 1 3 isolated metastatic sites, typically occurring more than six months after successful treatment of primary disease. 1 In
More informationUse of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation.
Radiation Therapy Use of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation. One person in three will develop some form of cancer in their lifetime.
More informationRadiation Health Effects
Radiation Health Effects Elena Buglova Incident and Emergency Centre Department of Nuclear Safety and Security Content Historical background Primary target for cell damage Deterministic effects Stochastic
More informationThe print quality of this copy is not an accurate representation of the original.
Cardiovasc Intervent Radiol DOI 10.1007/s00270-010-9945-4 TECHNICAL NOTE Staff Radiation Doses in a Real-Time Display Inside the Angiography Room Roberto Sanchez E. Vano J. M. Fernandez J. J. Gallego Received:
More informationIntensity modulated radiotherapy (IMRT) in bilateral retinoblastoma
194 case report Intensity modulated radiotherapy (IMRT) in bilateral retinoblastoma Banu Atalar 1, Enis Ozyar 1, Kaan Gunduz 2, Gorkem Gungor 3 1 Department of Radiation Oncology, Acibadem University Istanbul,
More informationEye-Preserving Therapy in Retinoblastoma: Prolonged Primary Chemotherapy Alone or Combined with Local Therapy
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2010;24(4):219-224 DOI: 10.3341/kjo.2010.24.4.219 Original Article Eye-Preserving Therapy in Retinoblastoma: Prolonged Primary Chemotherapy Alone or
More informationEVIDENCE BASED MANAGEMENT FOR Retinoblastoma
CLINICAL EVALUATION & STAGING EVIDENCE BASED MANAGEMENT FOR Retinoblastoma Symptoms & Signs : White eye reflex, squint, diminished vision, red eye, proptosis. History - Family history of retinoblastoma
More information"The Good Side of Radiation: Medical Applications"
"The Good Side of Radiation: Medical Applications" J. Battista, Ph.D. Medical Physicist London Regional Cancer Program LHSC http://www.macmillan.org.uk/images/cancerinfo Role of Medical Physicists Diagnostic
More informationAsk EuroSafe Imaging. Tips & Tricks. Paediatric Imaging Working Group. Shielding in pediatric CT
Ask EuroSafe Imaging Tips & Tricks Paediatric Imaging Working Group Shielding in pediatric CT Claudio Granata (IRCCS Istituto Giannina Gaslini, IT) Joana Santos (ESTeSC-Coimbra Health School, PT) Elina
More informationRole of ultrasound in congenital cataract: Our experience
Role of ultrasound in congenital cataract: Our experience Ayat Aziz Al-Alwan (1) Hazim Kamil Haddad (1) Rana Ahmad Alkrimeen (1) Mohammad Jalal Alsa aideh (2) Mu taz Ghalib Halasah (1) (1) Jordanian Royal
More informationCONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3
CONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3 PREAMBLE...9 Background...9 Objective and Scope...9 Selection of Topics for Monographs...10 Data for Monographs...11 The Working Group...11 Working
More informationCancer Risk. Klaus-Rüdiger Trott Università degli Studi di Pavia And University College London Cancer Isntitue and Technische Universität München
Cancer Risk Klaus-Rüdiger Trott Università degli Studi di Pavia And University College London Cancer Isntitue and Technische Universität München The aims of Radiation Protection The aims of Radiation Protection
More information1/31/2014. Radiation Biology and Risk to the Public
Radiation Biology and Risk to the Public Dr. David C. Medich University of Massachusetts Lowell Lowell MA 01854 Introduction Definition: Radiation Biology is the field of science that studies the biological
More informationRecent Progress in Radiation Dosimetry for Epidemiology and Radiological Protection. John Harrison ICRP Committee 2
Recent Progress in Radiation Dosimetry for Epidemiology and Radiological Protection John Harrison ICRP Committee 2 Joint ICRP-RERF-JHPS Workshop: Tokyo, December 2017 Task Group 79 : Use of Effective Dose
More informationHow to Develop CT Protocols for Children
How to Develop CT Protocols for Children Introduction Prior to 2001 the vast majority of CT imaging of children was conducted using the same or similar techniques used for adult imaging. In 2001, several
More informationCase Series and Brief Reports. Ocul Oncol Pathol 2017;3:34 40 DOI: /
Case Series and Brief Reports Received: April 14, 2016 Accepted after revision: July 24, 2016 Published online: September 14, 2016 Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection
More informationRadiation Cataract: Biomicroscopic Observations in Rabbit, Monkey, and Man*
Radiation Cataract: Biomicroscopic Observations in Rabbit, Monkey, and Man* WALTER J. GEERAETS, M.D. Professor of Ophthalmology and Associate Professor of Biophysics, Medical College of Virginia, Health
More informationDosimetry for Epidemiology Cohorts Who Receive Radiation Therapy
Dosimetry for Epidemiology Cohorts Who Receive Radiation Therapy Wayne Newhauser, PhD Eurados Winter School, Milan, 2016 Introduction About 1 in 2 men and women born today will be diagnosed with some form
More informationEvidence for variation in human radiosensitivity: potential impact on radiological protection
Evidence for variation in human radiosensitivity: potential impact on radiological protection Simon Bouffler 22 October 2015 ICRP Symposium 2015, Seoul, South Korea Current system of protection Avoid tissue
More informationUtility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer
Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department
More informationCLINICAL SCIENCES. Histopathologic Observations After Intra-arterial
ONLINE FIRST CLINICAL SCIENCES Histopathologic Observations After Intra-arterial Chemotherapy for Retinoblastoma Ralph C. Eagle Jr, MD; Carol L. Shields, MD; Carlos Bianciotto, MD; Pascal Jabbour, MD;
More information